PURE
PURE BIOSCIENCE, INC.Company Information
- Company Name
- PURE BIOSCIENCE, INC.
- CIK
- CIK0001006028
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PURE: OTC
- Fiscal Year End
- July 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 2890
- SIC Description
- Miscellaneous Chemical Products
- Ticker
- PURE
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-03-22
- Last sale
- 2020-12-19
- Shares purchased (TTM)
- 110,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2022-09-30
- Institutional shares owned
- 809,809
- Shares outstanding
- 111,356,473
- Ownership
- 0.73%
Earnings Market Reaction
- Filing date
- 2026-06-15
- Price on filing date
- —
- 1-month reaction
- -14.29%
- 3-month reaction
- 0.00%
Balance Sheet
Values in millions ($)| Line item | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash And Cash Equivalents | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | ||||||
| Convertible Notes Payable Current | 3 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Liabilities Noncurrent | - | - | - | - | - | 4 | 4 | 3 | 2 | 2 | 2 | 1 | ||||||
| Convertible Long Term Notes Payable | 4 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 7 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 3 | 2 | 3 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital | 134 | 133 | 133 | 133 | 133 | 133 | 133 | 133 | 133 | 133 | 132 | 132 | ||||||
| Retained Earnings Accumulated Deficit | -141 | -140 | -139 | -139 | -139 | -138 | -137 | -137 | -136 | -135 | -134 | -133 | ||||||
| Stockholders Equity | -6 | -6 | -6 | -5 | -5 | -4 | -3 | -3 | -2 | -1 | -0 | 0 | ||||||
| Liabilities And Stockholders Equity | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 150 | 150 | 150 | 200 | ||||||
| Common Stock Shares Issued | 130 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | ||||||
| Shares Outstanding | 130 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPURE BIOSCIENCE, INC. (PURE) — SEC Financial Statements & Analysis
PURE BIOSCIENCE, INC. (PURE) is a miscellaneous chemical products company, incorporated in DE. PURE BIOSCIENCE, INC. trades on OTC as: PURE. PURE BIOSCIENCE, INC. (PURE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-04-30, filed with the SEC on 2026-06-15. Based on that filing, PURE BIOSCIENCE, INC. carries a market cap of $7.76M, a P/E ratio of -3.52x, a P/B ratio of -1.33x, a P/S ratio of 3.20x, an enterprise value of $13.27M, and an EV/EBITDA multiple of -6.95x. On profitability, it posts a gross margin of 58.84%, an operating margin of -79.11%, a net margin of -91.04%, a Return on Equity (ROE) of 41.40%, a Return on Assets (ROA) of -168.64%, and a Return on Invested Capital (ROIC) of -193.78%. Per share, it reports EPS of $-0.02, diluted EPS of $-0.02, free cash flow per share of $-0.02, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 26.67% year-over-year, net income growth of -21.89% year-over-year, and EPS growth of -21.17% year-over-year. On the balance sheet, it maintains a current ratio of 0.42x, a quick ratio of 0.36x, working capital of $-2.10M, a debt-to-equity ratio of -1.27x, a debt ratio of 4.75, an interest coverage ratio of -4.91x, free cash flow of $-1.78M (TTM), and net debt of $5.51M. Figures sourced from SEC EDGAR.
- Market Cap
- $7.76M
- P/E TTM
- -3.52x
- EPS TTM
- $-0.02
- P/B TTM
- -1.33x
- ROE TTM
- 41.40%
- ROA TTM
- -168.64%
- Debt To Equity
- -1.27x
- Free Cash Flow TTM
- $-1.78M
- Net Revenue TTM Growth 1Y
- 26.67%
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PURE BIOSCIENCE, INC. in?
PURE BIOSCIENCE, INC. (PURE) operates in the Miscellaneous Chemical Products industry.
What exchange does PURE trade on?
PURE BIOSCIENCE, INC. (PURE) trades on the OTC.
Where is PURE BIOSCIENCE, INC. incorporated?
PURE BIOSCIENCE, INC. is incorporated in DE.
When was PURE BIOSCIENCE, INC. (PURE)'s most recent SEC filing?
PURE BIOSCIENCE, INC. (PURE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-04-30, filed with the SEC on 2026-06-15.
What is PURE's market cap?
PURE BIOSCIENCE, INC. (PURE) has a market capitalization of $7.76M as of 2026-04-30.
What is PURE's EPS (earnings per share)?
PURE BIOSCIENCE, INC. (PURE)'s trailing twelve month EPS is $-0.02 as of 2026-04-30.
What is PURE's ROE (return on equity)?
PURE BIOSCIENCE, INC. (PURE)'s trailing twelve month Return on Equity (ROE) is 41.40% as of 2026-04-30.
What is PURE's ROA (return on assets)?
PURE BIOSCIENCE, INC. (PURE)'s trailing twelve month Return on Assets (ROA) is -168.64% as of 2026-04-30.
What is PURE's ROIC (return on invested capital)?
PURE BIOSCIENCE, INC. (PURE)'s trailing twelve month Return on Invested Capital (ROIC) is -193.78% as of 2023-07-31.
What is PURE's EV/EBITDA?
PURE BIOSCIENCE, INC. (PURE)'s trailing twelve month EV/EBITDA is -6.95x as of 2026-04-30.